Clinical Trial Update: Early Insertion of Axillary Impella® With VA ECMO [NA]

View source ↗

Summary

Clinical trial update for early insertion of Axillary Impella with VA ECMO in cardiogenic shock; study terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Axillary Impella (Impella)
• VA ECMO

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cardiogenic Shock | NA | Status: TERMINATED | Results posted: 2021-06-29